Suppr超能文献

儿童期癌症幸存者的乳腺癌筛查。

Breast Cancer Screening in Survivors of Childhood Cancer.

机构信息

From the Departments of Radiology (Y.G., C.C., S.L.H.) and Pathology (C.A.P.), New York University School of Medicine, 160 E 34th St, New York, NY 10016.

出版信息

Radiographics. 2023 Apr;43(4):e220155. doi: 10.1148/rg.220155.

Abstract

Women who survived childhood cancers or cancers at a young age are at high risk for breast cancer later in life. The accentuated risk is notable among those treated at a young age with a high radiation dose but also extends to survivors treated with therapies other than or in addition to radiation therapy. The predisposing risk factors are complex. Advances in radiation therapy continue to curtail exposure, yet the risk of a second cancer has no dose threshold and a long latency period, and concurrent use of chemotherapy may have an additive effect on long-term risk of cancer. Early screening with annual mammography and MRI is recommended for chest radiation exposure of 10 Gy or greater, beginning 8 years after treatment or at age 25 years, whichever is later. However, there is a lack of recommendations for those at high risk without a history of radiation therapy. Because mortality after breast cancer among survivors is higher than in women with de novo breast cancer, and because there is a higher incidence of a second asynchronous breast cancer in survivors than that in the general population, regular screening is essential and is expected to improve mortality. However, awareness and continuity of care may be lacking in these young patients and is reflected in their poor screening attendance. The transition of care from childhood to adulthood for survivors requires age-targeted and lifelong strategies of education and risk prevention that are needed to improve long-term outcomes for these patients. RSNA, 2023 See the invited commentary by Chikarmane in this issue. Quiz questions for this article are available through the Online Learning Center.

摘要

患有儿童期癌症或年轻时癌症的女性在以后的生活中患乳腺癌的风险很高。在年轻时接受高剂量辐射治疗的患者中,这种风险更为显著,但也扩展到接受除放疗以外或联合放疗的治疗方法的幸存者。诱发风险因素很复杂。放射治疗的进展继续减少暴露,但二次癌症的风险没有剂量阈值且潜伏期长,同时使用化疗可能对癌症的长期风险有累加效应。对于胸部辐射暴露 10Gy 或以上的患者,建议从治疗后 8 年或 25 岁(以较晚者为准)开始,每年进行乳房 X 线摄影和 MRI 筛查。但是,对于没有放疗史的高危患者,目前还没有推荐意见。由于幸存者乳腺癌的死亡率高于新发乳腺癌患者,且幸存者中第二个不同时发生的乳腺癌的发病率高于普通人群,因此定期筛查至关重要,预计可改善死亡率。但是,这些年轻患者可能缺乏意识和持续护理,这反映在他们较差的筛查参与度上。幸存者从儿童期到成年期的护理过渡需要针对年龄的、终身的教育和风险预防策略,以改善这些患者的长期预后。RSNA,2023 请参阅本期特邀评论员 Chikarmane 的评论。本文的测验问题可通过在线学习中心获取。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验